Companies / VTRS vs ABBV
VTRS vs ABBV: Viatris and AbbVie
Viatris (VTRS) reported $14.3B in revenue against a -24.6% net margin, while AbbVie (ABBV) reported $61.2B at a 6.9% net margin, most recently.
| Metric | VTRS | ABBV |
|---|---|---|
| Revenue | $14.3B | $61.2B |
| Net Income | $-3.5B | $4.2B |
| Gross Margin | 35.1% | 70.2% |
| Operating Margin | -18.6% | 24.6% |
| EPS (Diluted) | $-3.00 | $2.36 |
| Free Cash Flow | $1.9B | $17.8B |
| Total Debt | $14.4B | $67.0B |
| P/E Ratio | n/m | 96.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $19.00 | $288.14 |
Free: last 5 years
| Fiscal year | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| VTRS Revenue | ••••• | ••••• | ••••• | $17.9B | $16.3B | $15.4B | $14.7B | $14.3B |
| ABBV Revenue | ••••• | ••••• | ••••• | $56.2B | $58.1B | $54.3B | $56.3B | $61.2B |